Connect with us

Business

Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 – FDA.gov

The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.

Published

on

post featured image
ADVERTISEMENT

For Immediate Release:
November 21, 2020
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older weighing at least 40 kilograms

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Girl Scouts Have Millions Of Unsold Cookies – NPR
Article feature image
Major investors reportedly up stakes in Stripe ahead of public listing – CNBC
Article feature image
Off-duty flight attendant allegedly choked a crew member and claimed to be seated next to a terrorist before being subdued, police report says – CNN